Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
Bo.Hong (talk | contribs)
2 edits
page selection
No edit summary
Line 1,514: Line 1,514:
|
|
|
|
| ||Snehal Patel (SP)
| ||Sumi Kitahara (SK)
|
|
|
|SP (prior AE)
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
Line 1,522: Line 1,522:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
Line 1,530: Line 1,530:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
Line 1,538: Line 1,538:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
Line 1,546: Line 1,546:
|
|
|?PENDING
|?PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
Line 1,554: Line 1,554:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
Line 1,562: Line 1,562:
|
|
|Complete
|Complete
|11/21/2021||SP
|11/21/2021||SK
|
|
|
|SP (prior AE)
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
Line 1,570: Line 1,570:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
Line 1,578: Line 1,578:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|    Severe Mosquito Bite  Allergy||Disease||
Line 1,586: Line 1,586:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
Line 1,594: Line 1,594:
|
|
|?PENDING
|?PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
Line 1,602: Line 1,602:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
Line 1,611: Line 1,611:
|Complete
|Complete
|9/26/2022
|9/26/2022
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
Line 1,620: Line 1,620:
|Complete
|Complete
|1/21/2021
|1/21/2021
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
Line 1,629: Line 1,629:
|PENDING
|PENDING
|
|
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
Line 1,638: Line 1,638:
|Complete
|Complete
|9/26/2022
|9/26/2022
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
Line 1,647: Line 1,647:
|PENDING
|PENDING
|
|
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
Line 1,656: Line 1,656:
|Complete
|Complete
|1/21/2021
|1/21/2021
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
Line 1,664: Line 1,664:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
Line 1,672: Line 1,672:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
Line 1,680: Line 1,680:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
Line 1,688: Line 1,688:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
Line 1,696: Line 1,696:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
Line 1,704: Line 1,704:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
Line 1,712: Line 1,712:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
Line 1,720: Line 1,720:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
Line 1,728: Line 1,728:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
Line 1,736: Line 1,736:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
Line 1,744: Line 1,744:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
Line 1,752: Line 1,752:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
Line 1,760: Line 1,760:
|
|
|
|
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
Line 1,769: Line 1,769:
|PENDING
|PENDING
|
|
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
Line 1,778: Line 1,778:
|PENDING
|PENDING
|
|
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
Line 1,786: Line 1,786:
|
|
|PENDING
|PENDING
| ||SP
| ||SK
|
|
|
|SP (prior AE)
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
Line 1,795: Line 1,795:
|Completed
|Completed
|09/23/2022
|09/23/2022
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
Line 1,804: Line 1,804:
|Completed
|Completed
|09/23/2022
|09/23/2022
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
Line 1,813: Line 1,813:
|PENDING
|PENDING
|
|
|SP
|SK
|
|
|
|SP (prior AE)
|-
|-
| || ||
| || ||
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"